Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKesson
Queensland Health
Harvard Business School
US Department of Justice
Mallinckrodt
Cerilliant
UBS
Federal Trade Commission

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,739,152

« Back to Dashboard

Summary for Patent: 5,739,152
Title: Pharmaceutical emulsion
Abstract:A pharmaceutical emulsion for intravenous administration is disclosed which comprises a) a short acting dihydropyridine compound; b) a lipid phase; c) an emulsifier and d) water or a buffer.
Inventor(s): Andersson; Kjell Hjalmar (Fjar.ang.s, SE), Byrod; Eva Kristina (Molndal, SE), Hansson; Anna-Carin (Goteborg, SE), Nordlander; Margareta (Askim, SE), Westerlund; Rolf Christer (Molndal, SE)
Assignee: Astra Aktiebolag (Sodertalje, SE)
Application Number:08/364,953
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use; Delivery;

Drugs Protected by US Patent 5,739,152

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,739,152

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9303744Nov 12, 1993
PCT Information
PCT FiledNovember 03, 1994PCT Application Number:PCT/SE94/01032
PCT Publication Date:May 18, 1995PCT Publication Number: WO95/13066

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Deloitte
Teva
Citi
US Army
Daiichi Sankyo
Boehringer Ingelheim
Cantor Fitzgerald
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.